ES458537A1 - Procedimiento para preparar encefalinas 2-y-3-sustituidas. - Google Patents

Procedimiento para preparar encefalinas 2-y-3-sustituidas.

Info

Publication number
ES458537A1
ES458537A1 ES458537A ES458537A ES458537A1 ES 458537 A1 ES458537 A1 ES 458537A1 ES 458537 A ES458537 A ES 458537A ES 458537 A ES458537 A ES 458537A ES 458537 A1 ES458537 A1 ES 458537A1
Authority
ES
Spain
Prior art keywords
enkephalins
substituted
analogs
addicting
enkephalin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES458537A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES458537A1 publication Critical patent/ES458537A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para preparar encefalinas 2- y 3-sustituidas, de fórmula H-Tyr-W-Phe-Y-OH en la que Y es Leu ó Met; W se elige del grupo consistente en *** Y la configuración estereoquímica de cada uno de los residuos aminoácidos óptimamente activos es D, L, ó DL;
ES458537A 1976-05-07 1977-05-06 Procedimiento para preparar encefalinas 2-y-3-sustituidas. Expired ES458537A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/684,321 US4028319A (en) 1976-05-07 1976-05-07 2 and 3-substituted enkephalins

Publications (1)

Publication Number Publication Date
ES458537A1 true ES458537A1 (es) 1978-04-01

Family

ID=24747593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES458537A Expired ES458537A1 (es) 1976-05-07 1977-05-06 Procedimiento para preparar encefalinas 2-y-3-sustituidas.

Country Status (11)

Country Link
US (1) US4028319A (es)
JP (1) JPS52139040A (es)
AU (1) AU508251B2 (es)
BE (1) BE854397A (es)
DE (1) DE2720152A1 (es)
ES (1) ES458537A1 (es)
FR (1) FR2397394A1 (es)
GB (1) GB1526617A (es)
NZ (1) NZ184020A (es)
SE (1) SE7705295L (es)
ZA (1) ZA772758B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4075190A (en) * 1977-03-14 1978-02-21 American Home Products Corporation Pentapeptide with morphine-like activity
US4198398A (en) * 1977-07-12 1980-04-15 Derek Hudson Enkephalin analogues
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
US4148786A (en) * 1978-06-26 1979-04-10 American Home Products Corporation Analgesic polypeptide
US4199499A (en) * 1978-08-24 1980-04-22 Eli Lilly And Company Pharmacologically active peptides
US4304715A (en) * 1979-06-08 1981-12-08 Derek Hudson Enkephalin analogues
EP0053029A1 (en) * 1980-11-24 1982-06-02 Peninsula Laboratories Incorporated Non enkephalin-like peptides, their production, compositions containing them, and their medical and veterinary use
ES2146651T3 (es) 1994-05-12 2000-08-16 Balazs Sarkadi Compuestos para anular resistencias a medicamentos.

Also Published As

Publication number Publication date
NZ184020A (en) 1979-12-11
FR2397394B1 (es) 1980-04-25
SE7705295L (sv) 1977-11-08
JPS52139040A (en) 1977-11-19
ZA772758B (en) 1978-06-28
BE854397A (fr) 1977-11-09
GB1526617A (en) 1978-09-27
AU508251B2 (en) 1980-03-13
US4028319A (en) 1977-06-07
FR2397394A1 (fr) 1979-02-09
AU2489777A (en) 1978-11-09
DE2720152A1 (de) 1977-11-17

Similar Documents

Publication Publication Date Title
NZ183605A (en) Hentriakontapeptides having opiate agonist activity
AU6223986A (en) Potent,selective opioid receptor agonists and antagonists
CY1721A (en) Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
MY101934A (en) Composition useful for producing analgesia
IT1177105B (it) 1-aril-1,4-diidro-5h-tetrazol-5-oni 4-sostituiti e relativi analoghi solforati con attivita' erbicida
ES458537A1 (es) Procedimiento para preparar encefalinas 2-y-3-sustituidas.
IT8419995A0 (it) Procedimento selettivo per il blocco di ricettori di 5ht2.
GB2160871B (en) Pharmacologically active substituted benzamides
ES2099344T3 (es) Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.
ZA881966B (en) Pharmacologically active substituted benzamides
DK316176A (da) Histamin h2-antagonister
ES542163A0 (es) Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht.
EP0190946A3 (en) Novel cyclic hexapeptide lhrh antagonists
ES438315A1 (es) Un procedimiento para preparar compuestos de decahidroiso- quinolina.
IT1157077B (it) Macchina per cucire con dispositivo per il taglio di rifilatura dell'articolo
ES549077A0 (es) Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina
JO1335B1 (en) Antifungal agents Vasopressin base seven hepatic peptide bond
PT82515B (pt) Processo para a preparacao de composicoes farmaceuticas contendo antagonistas de dopamina
ES2000714A6 (es) Un procedimiento para preparar derivados de tetrahidroisoquinoleina
DK316076A (da) Histamin h2-antagonister
ES2098263T3 (es) 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.
IT8719009A0 (it) Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
ES463782A1 (es) Un procedimiento para la preparacion de derivados de benza- zepina.
IT1164633B (it) 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici
ATE11410T1 (de) 17-cyclopropylmethyl-3-hydroxy-14-methoxy 7 alpha-methylmorphinan-6-on.